Bixiye
P22-20 eviCore to Become Final Reviewer on Appeals for Commercial Members
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2211 - 2220 ee natiijooyinka 3613
Bixiye
P24-20 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers - eviCore Healthcare Specialty Utilization Management (UM) Program
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Bixiye
2020 April Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2020
Bixiye
QP34-20 New Claims Status Online Messaging Available on Availity
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP33-20 Updates to Telemedicine/Telehealth and Telephone Call Reimbursement Policies
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP28-20 Updated Service Type Options for Surgery on Availity Portal
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP29-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Peanut Allergy
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP30-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
QP31-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Taariikhda uu dhaqangalayo Barnaamijka: Mar 25, 2020
Bixiye
2020 March Provider Press
Taariikhda uu dhaqangalayo Barnaamijka: 24, Feb 2020